Breast cancer is characterized by elevated glucose consumption resulting in increased
uptake of 18F-FDG. However, tracer uptake varies considerably among tumors imaged with …

PURPOSE: Variable uptake of the glucose analog 18fluorodeoxyglucose (FDG) has been
noticed in positron emission tomography (PET) studies of breast cancer patients, with low …

Breast cancer is associated with increased glucose consumption and can therefore be
visualised with the glucose analogue [18 F] 2-deoxy-2-fluoro-d-glucose (FDG) and positron …

Objectives To determine whether a correlation exists between maximum standardized
uptake value (SUV max) on 18 F-fluorodeoxyglucose positron emission tomography (FDG …

Positron emission tomography using the glucose analog fluorine-18 fluorodeoxyglucose
(FDG-PET) provides a unique means of non-invasive assessment of tumor metabolism …

BACKGROUND Positron emission tomography (PET) with 2‐deoxy‐2‐fluoro [18F]‐D‐
glucose (FDG) can provide quantitative information about tumor glucose metabolism. The …

PURPOSE To evaluate the diagnostic value of position emission tomographic (PET)
imaging with F-18 fluorodeoxyglucose (FDG) in differentiating between benign and …

The aim of this study was to determine the relationship between tumor blood flow and
glucose utilization in women with untreated primary breast carcinomas. Noninvasive …

Positron emission tomography (PET) scanning has gained widespread acceptance for the
diagnosis, staging, and management of a variety of malignancies, including breast cancer …

Intratumoral Distribution of Tritiated Fluorodeoxyglucose in Breast Carcinoma: I. Are
Inflammatory Cells Important? Page 1 In patients with breast cancer (4—6),and in those with a …